The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Direct Gene Transfer into Mouse Muscle in Vivo
Abstract
RNA and DNA expression vectors containing genes for chloramphenicol acetyltransferase, luciferase, and β-galactosidase were separately injected into mouse skeletal muscle in vivo. Protein expression was readily detected in all cases, and no special delivery system was required for these effects. The extent of expression from both the RNA and DNA constructs was comparable to that obtained from fibroblasts transfected in vitro under optimal conditions. In situ cytochemical staining for β-galactosidase activity was localized to muscle cells following injection of the β-galactosidase DNA vector. After injection of the DNA luciferase expression vector, luciferase activity was present in the muscle for at least 2 months.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1990, Wolff et al. (5) demonstrated that direct injection (”
From Nonviral delivery of self-amplifying RNA vaccines (2012) · cites this paper as [5]
In the citing paper
“Following initial studies in the early 1990s demonstrating that exogenous mRNA can direct protein expression in vivo, mRNA has emerged as a promising drug platform technology in recent years (Wolff et al, 1990; Jirikowski et al, 1992).”
From mRNA mediates passive vaccination against infectious agents, toxins, and tumors (2017) · cites this paper as Wolff et al, 1990
In the citing paper
“In principle, the improvement of RNA kinetics by these modifications is not restricted to DCs but is similar in K562 cells and may also be of interest for other cellular settings, such as T cells, 43 B cells, 44 and muscle cells, 45 which are attractive host cells for the expression of IVT RNA-encoded proteins.”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [45]
Citations
Cites
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
Selective extraction of polyoma DNA from infected mouse cell cultures
Hirt, B. (1967) · Journal of Molecular Biology · doi:10.1016/0022-2836(67)90307-5 · Cited by 5,102
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Self-citationFirefly Luciferase Gene: Structure and Expression in Mammalian Cells
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. E. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,088
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs
Krieg, P. A., & Melton, D. A. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7057 · Cited by 1,533
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. H., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,257
Cationic liposome-mediated transfection
Felgner, P. L., & RINGOLD, G. M. (1989) · Nature · doi:10.1038/337387a0 · Cited by 989
Self-citationCationic liposome-mediated RNA transfection.
Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911
Self-citationLineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer.
Price, J., Turner, D., & Cepko, C. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.156 · Cited by 870
Receptor-mediated gene delivery and expression in vivo.
Wu, G. Y., & Wu, C. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68081-0 · Cited by 636
Flagged first, then by citations
Research works printed but not linked: 3
- FELGNER, P.L., FOCUS 11: 21 (1989).
- FRANZINIARMSTRO.C, MYOLOGY: 125 (1986).
- MALONE, R.W., FOCUS 11: 61 (1989).
Cited by
Sorted by citations
Items 601–700 of 1,009
Inflammatory responses following direct injection of plasmid DNA into skeletal muscle
McMahon, J. M., Wells, K., Bamfo, J., Cartwright, M., & Wells, D. J. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300718 · Cited by 105
Esprit, A., de Mey, W., Shahi, R. B., Thielemans, K., Franceschini, L., & Breckpot, K. (2020) · Vaccines · doi:10.3390/vaccines8040776 · Cited by 112
“[100] described in 1990 that injection of naked mRNA in mouse skeletal muscles resulted in transfection of muscle cells with protein expression lasting for several days.”
BackgroundmRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients
Bidram, M., Zhao, Y., Shebardina, N. G., Baldin, A. V., Bazhin, A. V., Ganjalikhany, M. R., Zamyatnin, A. A., & Ganjalıkhani-Hakemi, M. (2021) · Vaccines · doi:10.3390/vaccines9101060 · Cited by 111
Feasibility, Safety, and Efficacy of Myoblast Transfer Therapy on Duchenne Muscular Dystrophy Boys
Law, P. K., Goodwin, T. G., Fang, Q., Duggirala, V., Larkin, C., Florendo, J. A., Kirby, D. S., Deering, M. B., Li, H. J., Chen, M., et al. (1992) · Cell Transplantation · doi:10.1177/0963689792001002-305 · Cited by 104
OKUDA, K., Bukawa, H., Hamajima, K., Kawamoto, S., Sekigawa, K., Yamada, Y., Tanaka, S., Ishii, N., AOKI, I., Nakamura, M., et al. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.933 · Cited by 104
Kramm, C. M., Sena‐Esteves, M., Barnett, F. H., Rainov, N. G., Schuback, D. E., Yu, J. S., Pechan, P. A., Paulus, W., Chiocca, E. A., & Breakefield, X. O. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00615.x · Cited by 103
Human gene therapy: a brief overview of the genetic revolution.
Misra, S. (2013) · PubMed · Cited by 103
Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
Sahu, I., Haque, A. K. M. A., Weidensee, B., Weinmann, P., & Kormann, M. S. D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.019 · Cited by 104
“The first study of in vitro-transcribed (IVT) mRNA in the late 1980s showed that this mRNA can be directly translated into a functional form immediately after transfection in vitro and in vivo.(9,10) This was shortly followed by a therapeutic application of mRNA in a temporary reversal of diabetes insipidus, unravelin…”
BackgroundMessenger RNA vaccine based on recombinant MS2 virus‐like particles against prostate cancer
Li, J., Sun, Y., Jia, T., Zhang, R., Zhang, K., & Wang, L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28482 · Cited by 103
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
Vajdy, M., Srivastava, I. K., Polo, J., Donnelly, J., O’Hagan, D. T., & Singh, M. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01288.x · Cited by 104
Klinman, D. M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.305 · Cited by 103
Fabb, S. A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.7.733 · Cited by 103
Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery
Raz, E., Dudler, J., Lotz, M., Baird, S. M., Berry, C. C., Eisenberg, R. A., & Carson, D. A. (1995) · Lupus · doi:10.1177/096120339500400409 · Cited by 103
Gene Therapy — Promise, Pitfalls, and Prognosis
Leiden, J. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331310 · Cited by 103
Novel Platforms for the Development of a Universal Influenza Vaccine
Kumar, A., Meldgaard, T. S., & Bertholet, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00600 · Cited by 106
“(154) demonstrated that the direct injection of messenger RNA (mRNA) intramuscularly resulted in the expression of the encoded protein in a mouse model.”
BackgroundHeart involvement in muscular dystrophies due to sarcoglycan gene mutations
Melacini, P., Fanin, M., Duggan, D. J., Freda, M. P., Berardinelli, A. L., Danieli, G. A., Barchitta, A., Hoffman, E. P., Volta, S. D., & Angelini, C. I. (1999) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199904)22:4 · Cited by 136
Transfection with aFGF cDNA Improves Wound Healing
Sun, L., Xu, L., Chang, H. S., Henry, F. A., Miller, R. M., Harmon, J. M., & Nielsen, T. B. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12286471 · Cited by 102
Direct gene transfer into muscle
Dankó, I., & Wolff, J. A. (1994) · Vaccine · doi:10.1016/0264-410x(94)90072-8 · Cited by 102
Self-citationA Review of Automated Microinjection Systems for Single Cells in the Embryogenesis Stage
Permana, S., Grant, E., Walker, G. M., & Yoder, J. A. (2016) · IEEE/ASME Transactions on Mechatronics · doi:10.1109/tmech.2016.2574871 · Cited by 101
Optimizing Plasmid-Based Gene Transfer for Investigating Skeletal Muscle Structure and Function
Schertzer, J. D., Plant, D. R., & Lynch, G. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.019 · Cited by 101
Basarkar, A., & Singh, J. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9710-4 · Cited by 101
Cui, Z. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54011-2 · Cited by 104
In vivo electroporation improves immune responses to DNA vaccination in sheep
Scheerlinck, J. Y., Karlis, J., Tjelle, T. E., Presidente, P. J. A., Mathiesen, I., & Newton, S. E. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.09.053 · Cited by 101
Tsuji, T., Hamajima, K., Ishii, N., Aoki, I., Fukushima, J., Xin, K.-Q., Kawamoto, S., Sasaki, S., Matsunaga, K., Ishigatsubo, Y., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270329 · Cited by 101
Chapter 9 Retroviral Gene Delivery
Federspiel, M. J., & Hughes, S. H. (1997) · Methods in cell biology · doi:10.1016/s0091-679x(08)60379-9 · Cited by 101
An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi
Luke, C. J., Carner, K., Liang, X., & Barbour, A. G. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.91 · Cited by 101
A Review of DNA Vaccines Against Influenza
Lee, L., Izzard, L., & Hurt, A. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01568 · Cited by 100
“DNA vaccines were initially tested in the murine model using intramuscular injection of naked plasmids to produce antigens in passively transfected myocytes (muscle cells) (57).”
BackgroundHaghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 125
Direct Cutaneous Gene Delivery in a Human Genetic Skin Disease
Choate, K. A., & Khavari, P. A. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.14-1659 · Cited by 100
Nonviral Approaches Satisfying Various Requirements for Effective in Vivo Gene Therapy.
Nishikawa, M., & Hashida, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.275 · Cited by 99
Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?
Čemažar, M., Golzio, M., Serša, G., Rols, M., & Teissié, J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778559740 · Cited by 100
Jones, M. K., Kawanaka, H., Baatar, D., Szabó, I., Tsugawa, K., Pai, R., Koh, G. Y., Kim, I., Sarfeh, I. J., & Tarnawski, A. S. (2001) · Gastroenterology · doi:10.1053/gast.2001.29308 · Cited by 100
Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo
Heller, L. C., Jaroszeski, M. J., Coppola, D., Pottinger, C., Gilbert, R., & Heller, R. F. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301173 · Cited by 100
Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies
Vilquin, J., Kennel, P., Paturneau-Jouas, M., Chapdelaine, P., Boissel, N., Delaère, P., Tremblay, J. P., Scherman, D., Fiszman, M. Y., & Schwartz, K. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301484 · Cited by 100
Johanning, F. W., Conry, R. M., LoBuglio, A. F., Wright, M., Sumerel, L. A., Pike, M. J., & Curiel, D. T. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.9.1495 · Cited by 99
Vincent, C. K., Gualberto, A., Patel, C. V., & Walsh, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.1264 · Cited by 99
DNA Vaccines: History, Molecular Mechanisms and Future Perspectives
Pagliari, S., Dema, B., Sánchez-Martínez, A., Zurbia-Flores, G. M., & Rollier, C. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168297 · Cited by 107
Gene expression in muscle in response to exercise.
Goldspink, G. (2003) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1026041228041 · Cited by 98
Environmental adaptations as windows on molecular evolution
Schulte, P. M. (2001) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s1096-4959(00)00357-2 · Cited by 98
Vaccine technologies: view to the future
Rabinovich, N. R., McInnes, P., Klein, D. L., & Hall, B. (1994) · Science · doi:10.1126/science.7521064 · Cited by 98
Legendre, J., & Szoka, F. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.893 · Cited by 98
Duclert, A., Duclert‐Savatier, N., Schaeffer, L., & Changeux, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17433 · Cited by 98
RNA therapeutics in the clinic
Curreri, A. M., Sankholkar, D., Mitragotri, S., & Zhao, Z. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10374 · Cited by 100
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
Kang, D. D., Li, H., & Dong, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114961 · Cited by 100
Engineering Synthetic Vectors for Improved DNA Delivery: Insights from Intracellular Pathways
Roth, C. M., & Sundaram, S. (2004) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.6.040803.140203 · Cited by 99
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens
Hartikka, J., Bozoukova, V., Ferrari, M. E., Sukhu, L., Enas, J. D., Sawdey, M., Wloch, M. K., Tonsky, K., Norman, J. A., Manthorpe, M., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00445-x · Cited by 97
Latta-Mahieu, M., Rolland, M., Caillet, C., Wang, M., Kennel, P., Mahfouz, I., Loquet, I., Dedieu, J.-F., Mahfoudi, A., Trannoy, E., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201707 · Cited by 114
Vaccinology in the post−COVID-19 era
Rappuoli, R., Gregorio, E. D., Giudice, G. D., Phogat, S. K., Pecetta, S., Pizza, M., & Hanon, E. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020368118 · Cited by 95
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
Saw, P. E., & Song, E. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101555 · Cited by 97
“93 Subsequent to this discovery, extensive preclinical investigations into IVT mRNA laid the foundation for the clinical development of mRNA vaccines targeting both cancer and infectious diseases.”
Bacteria as DNA vaccine carriers for genetic immunization
Schoen, C. U., Stritzker, J., Goebel, W., & Pilgrim, S. (2004) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.03.001 · Cited by 96
Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte, S. U., Joussen, A. M., von Recum, H. A., Poulaki, V., Moromizato, Y., Yuan, J., D’Amato, R. J., Kuo, C. J., & Adamis, A. P. (2001) · PubMed · Cited by 96
Nomura, T., Yasuda, K., Yamada, T., Okamoto, S., Mahato, R. I., Watanabe, Y., Takakura, Y., & Hashida, M. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300792 · Cited by 96
The ReNAissanCe of mRNA-based cancer therapy
Van Lint, S., Renmans, D., Broos, K., Dewitte, H., Lentacker, I., Heirman, C., Breckpot, K., & Thielemans, K. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.957685 · Cited by 95
The Pivotal Role of Chemical Modifications in mRNA Therapeutics
Liu, A., & Wang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.901510 · Cited by 102
Exosome-Based Carrier for RNA Delivery: Progress and Challenges
Lu, Y., Huang, W. C., Li, M., & Zheng, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020598 · Cited by 103
“Such vesicles were initially recognized as a minute “cellular dust” extruded on cell storage, or which acted as the mechanism of cellular waste disposal [7].”
BackgroundThe advances of adjuvants in mRNA vaccines
Xie, C., Yao, R., & Xia, X. (2023) · npj Vaccines · doi:10.1038/s41541-023-00760-5 · Cited by 102
“Since the 1990s, researchers have made successive attempts to use mRNA to produce target proteins and develop mRNA vaccines against infectious diseases in preclinical models 2,3 .”
BackgroundFunctional in vivo gene transfer into the myofibers of adult skeletal muscle
Donà, M., Sandri, M., Rossini, K., Dell’Aica, I., Podhorska‐Okołów, M., & Carraro, U. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.032 · Cited by 95
Lipid Carrier Systems for Targeted Drug and Gene Delivery
Hashida, M., Kawakami, S., & Yamashita, F. (2005) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.53.871 · Cited by 97
DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade
Giri, M. S., Ugen, K. E., & Weiner, D. B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.370-389.2004 · Cited by 95
A Plasmid-Based Self-Amplifying Sindbis Virus Vector
Herweijer, H., Latendresse, J. S., Williams, P., Zhang, G., Dankó, I., Schlesinger, S., & Wolff, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.9-1161 · Cited by 95
Self-citationFetal Gene Transfer by Intrauterine Injection with Microbubble-Enhanced Ultrasound
Endoh, M., Koibuchi, N., Sato, M., Morishita, R., Kanzaki, T., Murata, Y., & Kaneda, Y. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0577 · Cited by 94
Gu, M., Leppla, S. H., & Klinman, D. M. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00210-2 · Cited by 94
Gene therapy for tissue repair and regeneration
Bonadio, J. F., Goldstein, S. A., & Levy, R. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00020-9 · Cited by 94
Particle Bombardment-Mediated Gene Transfer and Expression in Rat Brain Tissues
Jiao, S., Cheng, L., Wolff, J. A., & Yang, N.-S. (1993) · Nature Biotechnology · doi:10.1038/nbt0493-497 · Cited by 94
Self-citationDesmin/vimentin intermediate filaments are dispensable for many aspects of myogenesis.
Schultheiss, T., Lin, Z. X., Ishikawa, H., Zamir, I., Stoeckert, C. J., & Holtzer, H. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.114.5.953 · Cited by 94
A Critical Review of Electroporation as A Plasmid Delivery System in Mouse Skeletal Muscle
Sokołowska, E., & Błachnio-Zabielska, A. U. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112776 · Cited by 100
“However, the effectiveness of plasmid-based gene delivery to muscle fibres by intramuscular injection still does not provide an efficient transfection [65,66].”
BackgroundPersonalized pancreatic cancer therapy: from the perspective of mRNA vaccine
Huang, X., Zhang, G., Tang, T., Gao, X., & Liang, T. (2022) · Military Medical Research · doi:10.1186/s40779-022-00416-w · Cited by 98
“Until 1990, in vitro transcribed mRNA was validated able to be template to produce proteins in mouse skeletal muscle cells in vivo [36].”
BackgroundIn Vitro Myotoxicity of Selected Cationic Macromolecules Used in Non-Viral Gene Delivery
Brazeau, G. A., Attia, S., Poxon, S. W., & Hughes, J. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011954516233 · Cited by 93
DNA vaccines: designing strategies against parasitic infections
Ivory, C. P. A., & Chadee, K. (2004) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-2-17 · Cited by 93
Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles
Louboutin, J. P., Fichter-Gagnepain, V., Thaon, E., & Fardeau, M. (1993) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)90098-5 · Cited by 91
Moorthy, V. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00771-5 · Cited by 93
Lewis, P. J., & Babiuk, L. A. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60367-x · Cited by 92
Kim, J. J., Yang, J.-S., Manson, K. H., & Weiner, D. B. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00479-5 · Cited by 93
Nucleic acid immunization: concepts and techniques associated with third generation vaccines
Hasan, U. A., Abai, A. M., Harper, D. R., Wren, B. W., & Morrow, W. J. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00104-0 · Cited by 92
Oral DNA Vaccination Promotes Mucosal and Systemic Immune Responses to HIV Envelope Glycoprotein
Kaneko, H., Bednarek, I. A., Wierzbicki, A. J., Kiszka, I., Dmochowski, M., Wasik, T. J., Kaneko, Y., & Kozbor, D. (2000) · Virology · doi:10.1006/viro.1999.0093 · Cited by 93
Quantitative analysis of the immunopotency of genetically transfected dendritic cells
Timares, L., Takashima, A., & Johnston, S. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13147 · Cited by 93
Hinkula, J., Svanholm, C., Schwartz, S., Lundholm, P., Brytting, M., Engström, G., Benthin, R., Glaser, H., Sutter, G., Kohleisen, B., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5528-5539.1997 · Cited by 93
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Tiptiri-Kourpeti, A., Spyridopoulou, K., Pappa, A., & Chlichlia, K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.05.004 · Cited by 94
DNA vaccination for finfish aquaculture
Collins, C., Lorenzen, N., & Collet, B. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.07.012 · Cited by 99
Engineering nanoparticle toolkits for mRNA delivery
Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 96
DNA Vaccines: Their Formulations, Engineering and Delivery
Kozak, M., & Hu, J. (2024) · Vaccines · doi:10.3390/vaccines12010071 · Cited by 100
“…vaccines were first put forth in the early 1990s when it was discovered that intramuscular plasmid DNA injection could induce protein expression, and importantly, it was concurrently shown that no special delivery system was necessary for most cells to take up DNA and route it to the nucleus [21].”
BackgroundDeterminants of Hepatitis C Translational Initiation in Vitro, in Cultured Cells and Mice
McCaffrey, A. P., Ohashi, K., Meuse, L. A., Shen, S., Lancaster, A. M., Lukavsky, P. J., Sarnow, P., & Kay, M. A. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0600 · Cited by 91
Grunwald, T., & Ulbert, S. (2015) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2015.4.1.1 · Cited by 93
Skin-targeted gene transfer using in vivo electroporation
Maruyama, H., Ataka, K., Higuchi, N., Sakamoto, F., Gejyo, F., & Miyazaki, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301604 · Cited by 92
High expression of naked plasmid DNA in muscles of young rodents
Dankó, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1435 · Cited by 92
Chapter 17 Gene Gun Transfection of Animal Cells and Genetic Immunization
Johnston, S. A., & Tang, D.-C. C. (1994) · Methods in cell biology · doi:10.1016/s0091-679x(08)60612-3 · Cited by 92
DNA immunization confers protection against murine cytomegalovirus infection
Armas, J. C. G., Morello, C. S., Cranmer, L. D., & Spector, D. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7921-7928.1996 · Cited by 92
Scientific and Social Issues of Human Immunodeficiency Virus Vaccine Development
Haynes, B. F. (1993) · Science · doi:10.1126/science.8493572 · Cited by 92
Chemical Modifications of mRNA Ends for Therapeutic Applications
Warminski, M., Mamot, A., Depaix, A., Kowalska, J., & Jemielity, J. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00442 · Cited by 91
Lobell, A., Weissert, R., Storch, M. K., Svanholm, C., de Graaf, K. L., Lassmann, H., Andersson, R., Olsson, T. P., & Wigzell, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1543 · Cited by 91
Walther, W., & Stein, U. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00210632 · Cited by 91
Non-viral gene transfer: Applications in developmental biology and gene therapy
Abdallah, B., Sachs, L. M., & DEMENEIX, B. A. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)89122-2 · Cited by 91
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Shin, H., Park, S. D., Yim, Y., Kim, J., Choi, C., Won, C., & Min, D. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800065 · Cited by 95
mRNA: A Novel Avenue to Antibody Therapy?
Schlake, T., Thran, M., Fiedler, K., Heidenreich, R., Petsch, B., & Fotin‐Mleczek, M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.002 · Cited by 93
Ilovitsh, T., Feng, Y., Foiret, J. L., Kheirolomoom, A., Zhang, H., Ingham, E. S., Ilovitsh, A., Tumbale, S. K., Fite, B. Z., Wu, B., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914906117 · Cited by 92
Frameworks for transformational breakthroughs in RNA-based medicines
Androsavich, J. R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00943-2 · Cited by 100
Soroudi, S., Jaafari, M. R., & Arabi, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.023 · Cited by 96
Plasmid DNA- and messenger RNA-based anti-cancer vaccination
Weide, B., Garbe, C., Rammensee, H., & Pascolo, S. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.09.012 · Cited by 90
Biotechnology and DNA vaccines for aquatic animals.
Kurath, G. (2008) · PubMed · Cited by 90
Recent advancements in regenerative dentistry: A review
Amrollahi, P., Shah, B., Seifi, A., & Tayebi, L. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.08.045 · Cited by 95
Metadata
- Authors
- Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L.
- Affiliations
- University of Wisconsin–Madison (US)
- Vical (United States) (US)
- Departments of Pediatrics and Genetics, Waisman Center, University of Wisconsin, Madison, WI 53706.
- Venue
- Science
- Published
- 1990-03-23
- Volume
- 247
- Issue
- 4949
- Pages
- 1465-1468
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2014495927
- Cited by
- 4,173
- References
- 27
- Citations by year
- 2026: 96 · 2025: 151 · 2024: 186 · 2023: 201 · 2022: 188 · 2021: 187 · 2020: 81 · 2019: 74 · 2018: 62 · 2017: 66 · 2016: 56 · 2015: 77 · 2014: 68 · 2013: 93 · 2012: 90
- FWCI
- 26.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k11hd000669-02)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 03352, HD00669-05, P30HD003352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
- Keywords
- in vivo gene delivery, skeletal muscle, intramuscular injection, DNA vectors, chloramphenicol acetyltransferase, luciferase, beta-galactosidase, transgene expression, cytochemical staining, transfection
- MeSH terms
- Animals, Avian Sarcoma Viruses, Coleoptera, beta-Galactosidase, DNA, Escherichia coli, Genetic Vectors, Histocytochemistry, Luciferases, Muscles, RNA, Transfection, Chloramphenicol O-Acetyltransferase, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review